“Nestle, the world’s biggest food group, has agreed to buy U.S. gastrointestinal diagnostics firm Prometheus Laboratories for an undisclosed sum as part of its drive into foods with health benefits.
Nestle said in a statement that Prometheus, which is expected to have annualized 2012 sales of around $250 million, focuses on conditions such as inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.”
If you enjoy the content at iBankCoin, please follow us on Twitter
